Correction: Fisher, Aron B., et al. A Peptide Inhibitor of NADPH Oxidase (NOX2) Activation Markedly Decreases Mouse Lung Injury and Mortality Following Administration of Lipopolysaccharide (LPS). Int. J. Mol. Sci. 2019, 20, 2395

Detalles Bibliográficos
Autores principales: Fisher, Aron B., Dodia, Chandra, Chatterjee, Shampa, Feinstein, Sheldon I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7014125/
https://www.ncbi.nlm.nih.gov/pubmed/31936343
http://dx.doi.org/10.3390/ijms21020398
_version_ 1783496557346160640
author Fisher, Aron B.
Dodia, Chandra
Chatterjee, Shampa
Feinstein, Sheldon I.
author_facet Fisher, Aron B.
Dodia, Chandra
Chatterjee, Shampa
Feinstein, Sheldon I.
author_sort Fisher, Aron B.
collection PubMed
description
format Online
Article
Text
id pubmed-7014125
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-70141252020-03-09 Correction: Fisher, Aron B., et al. A Peptide Inhibitor of NADPH Oxidase (NOX2) Activation Markedly Decreases Mouse Lung Injury and Mortality Following Administration of Lipopolysaccharide (LPS). Int. J. Mol. Sci. 2019, 20, 2395 Fisher, Aron B. Dodia, Chandra Chatterjee, Shampa Feinstein, Sheldon I. Int J Mol Sci Correction MDPI 2020-01-08 /pmc/articles/PMC7014125/ /pubmed/31936343 http://dx.doi.org/10.3390/ijms21020398 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Correction
Fisher, Aron B.
Dodia, Chandra
Chatterjee, Shampa
Feinstein, Sheldon I.
Correction: Fisher, Aron B., et al. A Peptide Inhibitor of NADPH Oxidase (NOX2) Activation Markedly Decreases Mouse Lung Injury and Mortality Following Administration of Lipopolysaccharide (LPS). Int. J. Mol. Sci. 2019, 20, 2395
title Correction: Fisher, Aron B., et al. A Peptide Inhibitor of NADPH Oxidase (NOX2) Activation Markedly Decreases Mouse Lung Injury and Mortality Following Administration of Lipopolysaccharide (LPS). Int. J. Mol. Sci. 2019, 20, 2395
title_full Correction: Fisher, Aron B., et al. A Peptide Inhibitor of NADPH Oxidase (NOX2) Activation Markedly Decreases Mouse Lung Injury and Mortality Following Administration of Lipopolysaccharide (LPS). Int. J. Mol. Sci. 2019, 20, 2395
title_fullStr Correction: Fisher, Aron B., et al. A Peptide Inhibitor of NADPH Oxidase (NOX2) Activation Markedly Decreases Mouse Lung Injury and Mortality Following Administration of Lipopolysaccharide (LPS). Int. J. Mol. Sci. 2019, 20, 2395
title_full_unstemmed Correction: Fisher, Aron B., et al. A Peptide Inhibitor of NADPH Oxidase (NOX2) Activation Markedly Decreases Mouse Lung Injury and Mortality Following Administration of Lipopolysaccharide (LPS). Int. J. Mol. Sci. 2019, 20, 2395
title_short Correction: Fisher, Aron B., et al. A Peptide Inhibitor of NADPH Oxidase (NOX2) Activation Markedly Decreases Mouse Lung Injury and Mortality Following Administration of Lipopolysaccharide (LPS). Int. J. Mol. Sci. 2019, 20, 2395
title_sort correction: fisher, aron b., et al. a peptide inhibitor of nadph oxidase (nox2) activation markedly decreases mouse lung injury and mortality following administration of lipopolysaccharide (lps). int. j. mol. sci. 2019, 20, 2395
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7014125/
https://www.ncbi.nlm.nih.gov/pubmed/31936343
http://dx.doi.org/10.3390/ijms21020398
work_keys_str_mv AT fisheraronb correctionfisheraronbetalapeptideinhibitorofnadphoxidasenox2activationmarkedlydecreasesmouselunginjuryandmortalityfollowingadministrationoflipopolysaccharidelpsintjmolsci2019202395
AT dodiachandra correctionfisheraronbetalapeptideinhibitorofnadphoxidasenox2activationmarkedlydecreasesmouselunginjuryandmortalityfollowingadministrationoflipopolysaccharidelpsintjmolsci2019202395
AT chatterjeeshampa correctionfisheraronbetalapeptideinhibitorofnadphoxidasenox2activationmarkedlydecreasesmouselunginjuryandmortalityfollowingadministrationoflipopolysaccharidelpsintjmolsci2019202395
AT feinsteinsheldoni correctionfisheraronbetalapeptideinhibitorofnadphoxidasenox2activationmarkedlydecreasesmouselunginjuryandmortalityfollowingadministrationoflipopolysaccharidelpsintjmolsci2019202395

Ejemplares similares